Tyler K. Nygaard

Tyler K. Nygaard

Auto-generated profile, based on publicly available information

Tyler K. Nygaard

Department of Immunology and Infectious Diseases, Montana State University, Bozeman, Montana, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Cell Host & Microbe
Verified
Journal Article
Closed access
SNSeitaro Nakagawa
Seitaro Nakagawa
MMMasanori Matsumoto
Masanori Matsumoto
YKYuki Katayama
Yuki Katayama
RORena Oguma
Rena Oguma
SWSeiichiro Wakabayashi
Seiichiro Wakabayashi
YNYumi Nakamura
Yumi Nakamura

1 June 2009 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JVJovanka Voyich
Jovanka Voyich
CVCuong Vuong
Cuong Vuong
MDMark DeWald
Mark DeWald
TNTyler K. Nygaard
Tyler K. Nygaard
SKStanislava Kocianova
Stanislava Kocianova
FDFrank R. DeLeo
Frank R. DeLeo
Methicillin-resistant Staphylococcus aureus is problematic both in hospitals and in the community. Currently, we have limited understanding of mechani

2 December 2010 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
ADAshley L. DuMont
Ashley L. DuMont
TNTyler K. Nygaard
Tyler K. Nygaard
RWRobert L. Watkins
Robert L. Watkins
ASAmanda Smith
Amanda Smith
LKLina Kozhaya
Lina Kozhaya
VTVictor Torres
Victor Torres
Staphylococcus aureus is an important pathogen that continues to be a significant global health threat because of the prevalence of methicillin-resistant S. aureus strains (MRSA). The pathogenesis of this organism is partly attributed to the production of a large repertoire of cytotoxins that target and kill innate immune cells, which provide the first line of defence against S. aureus infection. Here we demonstrate that leukocidin A/B (LukAB) is required and sufficient for the ability of S. aureus, including MRSA, to kill human neutrophils, macrophages and dendritic cells. LukAB targets the plasma membrane of host cells resulting in cellular swelling and subsequent cell death. We found that S. aureus lacking lukAB are severely impaired in their ability to kill phagocytes during bacteria–phagocyte interaction, which in turn renders the lukAB-negative staphylococci more susceptible to killing by neutrophils. Notably, we show that lukAB is expressed in vivo within abscesses in a murine infection model and that it contributes significantly to pathogenesis of MRSA in an animal host. Collectively, these results extend our understanding of how S. aureus avoids phagocyte-mediated clearance, and underscore LukAB as an important factor that contributes to staphylococcal pathogenesis.

15 January 2010 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
TNTyler K. Nygaard
Tyler K. Nygaard
KPKyler B. Pallister
Kyler B. Pallister
PRPeter Ruzevich
Peter Ruzevich
SGShannon Griffith
Shannon Griffith
CVCuong Vuong
Cuong Vuong
JVJovanka Voyich
Jovanka Voyich
This investigation examines the role of the SaeR/S 2-component system in USA300, a prominent circulating clone of community-associated methicillin-re

4 May 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TNTyler K. Nygaard
Tyler K. Nygaard
KPKyler B. Pallister
Kyler B. Pallister
ADAshley L. DuMont
Ashley L. DuMont
MDMark DeWald
Mark DeWald
RWRobert L. Watkins
Robert L. Watkins
JVJovanka Voyich
Jovanka Voyich
This investigation examines the influence of alpha-toxin (Hla) during USA300 infection of human leukocytes. Survival of an USA300 isogenic deletion mutant of hla (USA300Δhla) in human blood was comparable to the parental wild-type strain and polymorphonuclear leukocyte (PMN) plasma membrane permeability caused by USA300 did not require Hla. Flow cytometry analysis of peripheral blood mononuclear cells (PBMCs) following infection by USA300, USA300Δhla, and USA300Δhla transformed with a plasmid over-expressing Hla (USA300Δhla Comp) demonstrated this toxin plays a significant role inducing plasma membrane permeability of CD14+, CD3+, and CD19+ PBMCs. Rapid plasma membrane permeability independent of Hla was observed for PMNs, CD14+ and CD19+ PBMCs following intoxication with USA300 supernatant while the majority of CD3+ PBMC plasma membrane permeability induced by USA300 required Hla. Addition of recombinant Hla to USA300Δhla supernatant rescued CD3+ and CD19+ PBMC plasma membrane permeability generated by USA300 supernatant. An observed delay in plasma membrane permeability caused by Hla in conjunction with Annexin V binding and ApoBrdU Tunel assays examining PBMCs intoxicated with recombinant Hla or infected with USA300, USA300Δhla, USA300Δhla Comp, and USA300ΔsaeR/S suggest Hla induces programmed cell death of monocytes, B cells, and T cells that results in plasma membrane permeability. Together these findings underscore the importance of Hla during S. aureus infection of human tissue and specifically demonstrate Hla activity during USA300 infection triggers programmed cell death of human monocytes, T cells and B cells that leads to plasma membrane permeability.

1 April 2013 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
MOMichael E. Olson
Michael E. Olson
TNTyler K. Nygaard
Tyler K. Nygaard
LALaynez Ackermann
Laynez Ackermann
RWRobert L. Watkins
Robert L. Watkins
OZOliwia W. Zurek
Oliwia W. Zurek
JVJovanka Voyich
Jovanka Voyich
Several prominent bacterial pathogens secrete nuclease (Nuc) enzymes that have an important role in combating the host immune response. Early studies of Staphylococcus aureus Nuc attributed its regulation to the agr quorum-sensing system. However, recent microarray data have indicated that nuc is under the control of the SaeRS two-component system, which is a major regulator of S. aureus virulence determinants. Here we report that the nuc gene is directly controlled by the SaeRS two-component system through reporter fusion, immunoblotting, Nuc activity measurements, promoter mapping, and binding studies, and additionally, we were unable identify a notable regulatory link to the agr system. The observed SaeRS-dependent regulation was conserved across a wide spectrum of representative S. aureus isolates. Moreover, with community-associated methicillin-resistant S. aureus (CA MRSA) in a mouse model of peritonitis, we observed in vivo expression of Nuc activity in an SaeRS-dependent manner and determined that Nuc is a virulence factor that is important for in vivo survival, confirming the enzyme's role as a contributor to invasive disease. Finally, natural polymorphisms were identified in the SaeRS proteins, one of which was linked to Nuc regulation in a CA MRSA USA300 endocarditis isolate. Altogether, our findings demonstrate that Nuc is an important S. aureus virulence factor and part of the SaeRS regulon.